Pages that link to "Q40492600"

The following pages link to The multi-targeted kinase inhibitor SU5416 inhibits small cell lung cancer growth and angiogenesis, in part by blocking Kit-mediated VEGF expression (Q40492600):

Displaying 20 items.

• Structural and functional properties of platelet-derived growth factor and stem cell factor receptors (Q26829546) (← links)
• VEGF receptor inhibition blocks liver cyst growth in pkd2(WS25/-) mice (Q28506974) (← links)
• Multitarget inhibitors derived from crosstalk mechanism involving VEGFR2. (Q35434188) (← links)
• The treatment of high grade gliomas and diffuse intrinsic pontine tumors of childhood and adolescence: a historical - and futuristic - perspective (Q36273008) (← links)
• State of the art chemotherapeutic management of pediatric brain tumors (Q36492376) (← links)
• Clinical implications for vascular endothelial growth factor in the lung: friend or foe? (Q36625050) (← links)
• Novel therapies for the treatment of small-cell lung cancer: a time for cautious optimism? (Q36651648) (← links)
• Hepatic Radiofrequency Ablation-induced Stimulation of Distant Tumor Growth Is Suppressed by c-Met Inhibition (Q36762751) (← links)
• Targeted therapies in small-cell lung cancer (Q36897340) (← links)
• Genetic changes in small cell lung carcinoma. (Q37138250) (← links)
• Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors (Q37416895) (← links)
• Activation of corticotropin-releasing factor receptor 2 inhibits the growth of human small cell lung carcinoma cells (Q39766058) (← links)
• A sequential, multiple-treatment, targeted approach to reduce wound healing and failure of glaucoma filtration surgery in a rabbit model (an American Ophthalmological Society thesis). (Q42940255) (← links)
• Phase II trial of sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancer. (Q45304925) (← links)
• Why is cancer drug discovery so difficult? (Q45965493) (← links)
• C-kit protein expression correlated with activating mutations in KIT gene in oral mucosal melanoma (Q46860938) (← links)
• Inhibition of fibroblast growth factor receptor with AZD4547 mitigates juvenile nasopharyngeal angiofibroma. (Q50891198) (← links)
• SU5416 attenuated lipopolysaccharide-induced acute lung injury in mice by modulating properties of vascular endothelial cells. (Q64969864) (← links)
• SU5416 does not attenuate early RV angiogenesis in the murine chronic hypoxia PH model. (Q64977643) (← links)
• Apatinib in patients with extensive-stage small-cell lung cancer after second-line or third-line chemotherapy: a phase II, single-arm, multicentre, prospective study (Q90114862) (← links)